Medical tests

Genetic Testing Will Be the Talk of the Table this Thanksgiving

Retrieved on: 
Wednesday, November 21, 2018
Christmas economics, Buzzword, Medicine, Medical genetics, Culture, Trade, Medical tests, E-commerce, Genetic testing, Black Friday, Cyber Monday, Thanksgiving

This Thanksgiving, as families gather around the dinner table and discuss heritage and history, genetic testing is sure to be on the menu. Genetic testing companies are offering Black Friday and Cyber Monday discounts on kits to help you discover your genealogy and are sure to report record sales.

Key Points: 
  • This Thanksgiving, as families gather around the dinner table and discuss heritage and history, genetic testing is sure to be on the menu.
  • Genetic testing companies are offering Black Friday and Cyber Monday discounts on kits to help you discover your genealogy and are sure to report record sales.
  • And as with any family discussion, navigating serious or sensitive topics takes thoughtfulness and diplomacy; choosing a genetic testing provider also calls for careful consideration.
  • Because genetic information is so sensitive, youll want to know how a company will protect and use genetic data before buying Grandpa a kit on Black Friday.

Alzheimer's Foundation of America Advises Consumers: Be Informed before Using an At-Home Genetic Testing Kit this Holiday Season

Retrieved on: 
Wednesday, November 21, 2018
Medical genetics, Biology, Medicine, Clinical medicine, Medical tests, Genetic counseling, Genetic testing, Genetics, Elective genetic and genomic testing, Draft:Genetic counselor

At-home genetic testing kits provide information about ancestry and, potentially, genetic risk for medical conditions.

Key Points: 
  • At-home genetic testing kits provide information about ancestry and, potentially, genetic risk for medical conditions.
  • "As with any health decision, consumers should have the right information before deciding to take a genetic test."
  • AFA advises consumers of the following before getting a genetic test:
    Be informed: Genetic testing has potential positive and negative impacts.
  • Consider genetic counseling: Genetic counselors are experts trained to explain genetic testing, answer questions, interpret test results and refer you to other healthcare providers and support services as necessary.

The Global Electrocardiograph (ECG) Market size is expected to reach $7.4 billion by 2024, rising at a market growth of 6.1% CAGR during the forecast period

Retrieved on: 
Monday, November 19, 2018
Medicine, Clinical medicine, Circulatory system, Medical tests, Electrodiagnosis, Cardiac electrophysiology, Electrophysiology, Electrocardiography, Heart, Lead

LONDON, Nov. 19, 2018 /PRNewswire/ -- The Global Electrocardiograph (ECG) Market size is expected to reach $7.4 billion by 2024, rising at a market growth of 6.1% CAGR during the forecast period.

Key Points: 
  • LONDON, Nov. 19, 2018 /PRNewswire/ -- The Global Electrocardiograph (ECG) Market size is expected to reach $7.4 billion by 2024, rising at a market growth of 6.1% CAGR during the forecast period.
  • The electrodes detect minutest electrical changes in the skin which is caused due to heart muscle depolarizing during each heartbeat.
  • Technological advancements of ECG devices like portability, handheld, novel electrodes & sensors, and smart phone integration are likely to contribute to the market growth.
  • On the basis of Lead Type, the market is segmented into Single Lead ECG, 3-6 Lead ECG, 12 Lead ECG.

Global In-Vitro Diagnostics Market Size, Share & Trends Analysis Report 2018-2025: Reagent Segment Held the Largest Market Share of 64.6% in 2017

Retrieved on: 
Friday, November 16, 2018
Medicine, Biology, Medical tests, Biotechnology, Molecular diagnostics, IVD, In vitro, Clinical medicine

The "In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent, Service), By Technology (Clinical Chemistry, Molecular Diagnostics, Microbiology), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent, Service), By Technology (Clinical Chemistry, Molecular Diagnostics, Microbiology), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global in vitro diagnostics (IVD) market size is expected to reach USD 98.99 billion by 2025 and is anticipated to expand at a CAGR of 6.6% over the forecast period.
  • Increasing geriatric population, which is prone to many diseases and in need of regular diagnostic tests, is one of the major drivers for this market.
  • Furthermore, rising prevalence cardiovascular disorders, cancer, diabetes, and other chronic diseases coupled with increasing demand for onsite diagnostics is expected to further propel the in vitro diagnostics (IVD) market.

The global in vitro diagnostics (IVD) market size is expected to reach USD 98.99 billion by 2025

Retrieved on: 
Wednesday, November 14, 2018
Medicine, Biology, Medical tests, Biotechnology, Molecular diagnostics, IVD, In vitro, Clinical medicine

NEW YORK, Nov. 14, 2018 /PRNewswire/ -- In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent, Service), By Technology (Clinical Chemistry, Molecular Diagnostics, Microbiology), And Segment Forecasts, 2018 - 2025

Key Points: 
  • NEW YORK, Nov. 14, 2018 /PRNewswire/ -- In Vitro Diagnostics (IVD) Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent, Service), By Technology (Clinical Chemistry, Molecular Diagnostics, Microbiology), And Segment Forecasts, 2018 - 2025
    The global in vitro diagnostics (IVD) market size is expected to reach USD 98.99 billion by 2025, according to a new report by Grand View Research, Inc.
  • Increasing geriatric population, which is prone to many diseases and in need of regular diagnostic tests, is one of the major drivers for this market.
  • Furthermore, rising prevalence cardiovascular disorders, cancer, diabetes, and other chronic diseases coupled with increasing demand for onsite diagnostics is expected to further propel the in vitro diagnostics (IVD) market.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Invitae Highlighting New Research, Honoring Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 37th Annual Conference

Retrieved on: 
Wednesday, November 14, 2018
Medicine, Genetics, Clinical medicine, Medical tests, Medical genetics, Genetic counseling, Genetic testing, Forward-looking statement, Down syndrome, Screening

In addition to its research presentations, the company is supporting the Code Talker award, which recognizes excellence in the field of genetic counseling.

Key Points: 
  • In addition to its research presentations, the company is supporting the Code Talker award, which recognizes excellence in the field of genetic counseling.
  • Of all individuals evaluated, including both probands and healthy parents, 3.6 percent showed a medically significant finding in ACMG59 genes associated with personal disease risk.
  • These findings support expanding access to genetic screening for hereditary risk information in healthy individuals.
  • These forward-looking statements speak only as of the date hereof, and Invitae Corporation disclaims any obligation to update these forward-looking statements.

2018 POC Infectious Disease Market

Retrieved on: 
Tuesday, November 13, 2018
Epidemiology, Infection, Medical tests

- Market shares of major infectious disease diagnostic reagent and instrument suppliers.

Key Points: 
  • - Market shares of major infectious disease diagnostic reagent and instrument suppliers.
  • - Analysis of infectious disease diagnostic tests performed in POC testing locations.
  • - Review of leading infectious disease testing analyzers, both currently marketed and
    - Emerging technologies and their applications for POC testing.
  • - Specific opportunities for new infectious disease testing instruments and reagent systems with potentiallysignificant market appeal during the next five years.

2018 POC Hematology and Flow Cytometry Markets

Retrieved on: 
Tuesday, November 13, 2018
Biology, Laboratory techniques, Flow cytometry, Clinical pathology, Medicine, Cell biology, Chemistry, Medical tests, Cytometry, Assay

- Analysis of hematology and flow cytometry procedures performed in POC testing locations.

Key Points: 
  • - Analysis of hematology and flow cytometry procedures performed in POC testing locations.
  • - Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
  • hematology and flow cytometry testing technologies and products, by assay.
  • - Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years.

Expanding Applications of NX Prenatal's Exosome-Based Diagnostics Platform Presented at Key Conferences

Retrieved on: 
Tuesday, November 13, 2018
Medicine, Clinical medicine, Medical tests, Biotechnology, Biopsy, Biomarkers, Molecular diagnostics, Exosome, Liquid biopsy, NX technology, Siemens NX

HOUSTON and LOUISVILLE,Ky., Nov. 13, 2018 /PRNewswire/ --NX Prenatal Inc., a privately held women's healthcare molecular diagnostic company, announced today that expanding applications of its proprietary NeXosome liquid biopsy platform were presented at recent scientific conferences.

Key Points: 
  • HOUSTON and LOUISVILLE,Ky., Nov. 13, 2018 /PRNewswire/ --NX Prenatal Inc., a privately held women's healthcare molecular diagnostic company, announced today that expanding applications of its proprietary NeXosome liquid biopsy platform were presented at recent scientific conferences.
  • Dr. Haas also presented methodological data demonstrating the effectiveness of the NeXosome platform in enriching maternal plasma samples for placental-derived exosomes, underscoring important "liquid biopsy" capabilities of NX Prenatal's technology platform.
  • NX Prenatal Inc. is a private, US-based molecular diagnostics company.
  • NX Prenatal has demonstrated the clinical utility of its biomarker panels for prenatal risk assessment as early as 10 weeks gestation.

New Diagnostic Test Helps Hospitals More Quickly Identify and Treat Emerging Antibiotic-Resistant Bacteria

Retrieved on: 
Tuesday, November 13, 2018
Etest, Microbiology, Antibiotic sensitivity, Phoenix, Medicine, Biology, Clinical pathology, Medical tests

The test is included on BD Phoenix gram-negative panels, allowing hospital labs to offer it as part of routine antibiotic susceptibility testing.

Key Points: 
  • The test is included on BD Phoenix gram-negative panels, allowing hospital labs to offer it as part of routine antibiotic susceptibility testing.
  • The test streamlines laboratory workflow by routine, concurrent testing of CPO and susceptibility to one panel.
  • Conventional phenotypic methods for CPO detection can take up to 96 hours, whereas the BD Phoenix CPO detect test can accurately detect CPOs in under 36 hours.
  • All versions of the BD Phoenix CPO detect test will be available beginning in January 2019.